Sign in
Back
Update in thrombosis: answers to perplexing questions
Journal article   Peer reviewed

Update in thrombosis: answers to perplexing questions

Daniel G Federman, Gina R Brescia, John P Moriarty, Sally G Haskell, Raj Krishnamurthy and Robert S Kirsner
Cleveland Clinic journal of medicine, Vol.72(10), pp.907-915
2005-10
DOI: https://doi.org/10.3949/ccjm.72.10.907
PMID: 16231687

Abstract

Anticoagulants - administration & dosage Venous Thrombosis - drug therapy Humans Risk Factors Anticoagulants - therapeutic use Clinical Trials as Topic Secondary Prevention Warfarin - administration & dosage Warfarin - therapeutic use Factor V Thromboembolism - drug therapy Venous Thrombosis - genetics Thromboembolism - genetics
Recent clinical trials are answering some of the perplexing clinical questions about venous thromboembolism (VTE), such as the length and intensity of anticoagulation needed to prevent recurrence. We review some of these clinical trials and their implications for physicians and patients.

Metrics

13 Record Views
1 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.75 Blood Clotting
1.75.271 Pulmonary Embolism
Web Of Science research areas
Medicine, General & Internal
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details